|92.47||+1.47 / +1.62%|
Data as of 3:59pm ET
|92.48||+0.0111 / +0.01%|
The 8 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 110.50, with a high estimate of 119.00 and a low estimate of 98.00. The median estimate represents a +19.50% increase from the last price of 92.47.
The current consensus among 9 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.